Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of the Booster Dose of Polio Vaccine Immunization Using Sabin IPV or bOPV at Children Aged 4 Years With Different Three Sequential Schedules History by Sabin IPV or bOPV in China

NCT04576910 is registered in ClinicalTrials.gov with Zhejiang Provincial Center for Disease Control and Prevention as lead sponsor.

NCT NCT04576910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04576910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of the Booster Dose of Polio Vaccine Immunization Using Sabin IPV or bOPV at Children Aged 4 Years With Different Three Sequential Schedules History by Sabin IPV or bOPV in China
Lead sponsor
Zhejiang Provincial Center for Disease Control and Prevention
Phase
Phase 4
Overall status
Completed
Start date
November 5, 2020
Completion date
December 31, 2021
Enrollment
387 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

polio, vaccine reaction